-
公开(公告)号:US20100056507A1
公开(公告)日:2010-03-04
申请号:US12447437
申请日:2007-10-26
申请人: Lydie Poitout , Jeremiah Harnett , Dennis Bigg , Carole Sackur , Eric Ferrandis
发明人: Lydie Poitout , Jeremiah Harnett , Dennis Bigg , Carole Sackur , Eric Ferrandis
IPC分类号: A61K31/536 , C07C69/76 , A61K31/235 , C07D271/10 , A61K31/4245 , C07D271/06 , C07D215/00 , A61K31/47 , C07D265/36 , C07D285/12 , A61K31/433 , A61P35/00 , A61P37/06 , A61P1/00 , A61P29/00
CPC分类号: C07D271/107 , C07D215/48 , C07D263/32 , C07D271/06 , C07D285/12 , C07D311/80 , C07D413/12
摘要: The present invention relates to new phenylic derivatives exhibiting a good affinity for certain sub-types of cannabinoid receptors, in particular the CB2 receptors. These derivatives are of particular interest in a method for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said new phenylic derivatives and to methods for the preparation and use thereof.
摘要翻译: 本发明涉及对某些亚型大麻素受体,特别是CB 2受体表现出良好亲和力的新的苯基衍生物。 这些衍生物在治疗涉及一种或多种大麻素受体的病理状况和疾病的方法中是特别有意义的。 本发明还涉及含有所述新的苯基衍生物的药物组合物及其制备和使用方法。
-
公开(公告)号:US20090325933A1
公开(公告)日:2009-12-31
申请号:US12375212
申请日:2007-07-13
申请人: Lydie Poitout , Carole Sackur , Eric Ferrandis
发明人: Lydie Poitout , Carole Sackur , Eric Ferrandis
IPC分类号: A61K31/519 , C07D495/04 , A61K31/5377 , A61K31/55 , A61P35/00 , A61P29/00 , A61P37/00 , A61P19/00 , A61P25/00
CPC分类号: C07D495/04
摘要: The present application relates to new pyrimidinone derivatives. These products have a good affinity for certain sub-types of cannabinoid receptors, especially the CB2 receptors. They are particularly attractive for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a drug.
摘要翻译: 本申请涉及新的嘧啶酮衍生物。 这些产品对某些亚型大麻素受体,特别是CB2受体具有良好的亲和力。 它们对于治疗涉及一种或多种大麻素受体的病理状况和疾病特别有吸引力。 本发明还涉及含有所述产品的药物组合物及其制备药物的用途。
-
公开(公告)号:US08236965B2
公开(公告)日:2012-08-07
申请号:US12317470
申请日:2008-12-23
IPC分类号: A61K31/4184 , C07D235/30
CPC分类号: C07D231/12 , C07D233/56 , C07D235/28 , C07D235/30 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/06 , C07D471/04 , C07D471/10
摘要: A subject of the present application is new benzimidazole derivatives of formula in which A, Y, R1, R2, R3 and R4 represent different variable groups. These products have an antagonist activity of GnRH (Gonadotropin-Releasing Hormone). The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
摘要翻译: 本申请的主题是新的苯并咪唑衍生物,其中A,Y,R 1,R 2,R 3和R 4表示不同的可变基团。 这些产物具有GnRH(促性腺激素释放激素)的拮抗剂活性。 本发明还涉及含有所述产品的药物组合物及其用于制备药物的用途。
-
公开(公告)号:US20050049290A1
公开(公告)日:2005-03-03
申请号:US10499384
申请日:2002-12-20
IPC分类号: A61K31/4184 , A61K31/427 , A61K31/437 , A61K31/438 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/5377 , A61K31/551 , A61P5/24 , A61P13/08 , A61P15/00 , A61P35/00 , A61P43/00 , C07D235/28 , C07D235/30 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , C07D417/06 , C07D471/04 , C07D471/10 , C07D521/00 , A61K31/655 , C07D45/02
CPC分类号: C07D231/12 , C07D233/56 , C07D235/28 , C07D235/30 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/06 , C07D471/04 , C07D471/10
摘要: A subject of the present application is new benzimidazole derivatives of formula in which A, Y, R1, R2, R3 and R4 represent different variable groups. These products have an antagonist activity of GnRH (Gonadotropin-Releasing Hormone). The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
摘要翻译: 本申请的主题是新的苯并咪唑衍生物,其中A,Y,R 1,R 2,R 3和R 4表示不同的可变基团。 这些产物具有GnRH(促性腺激素释放激素)的拮抗剂活性。 本发明还涉及含有所述产品的药物组合物及其用于制备药物的用途。
-
公开(公告)号:US20090170922A1
公开(公告)日:2009-07-02
申请号:US12317470
申请日:2008-12-23
IPC分类号: A61K31/4747 , A61K31/4164 , C07D401/04 , C07D235/04 , A61P35/00
CPC分类号: C07D231/12 , C07D233/56 , C07D235/28 , C07D235/30 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/06 , C07D471/04 , C07D471/10
摘要: A subject of the present application is new benzimidazole derivatives of formula in which A, Y, R1, R2, R3 and R4 represent different variable groups. These products have an antagonist activity of GnRH (Gonadotropin-Releasing Hormone). The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
摘要翻译: 本申请的主题是新的苯并咪唑衍生物,其中A,Y,R 1,R 2,R 3和R 4表示不同的可变基团。 这些产物具有GnRH(促性腺激素释放激素)的拮抗剂活性。 本发明还涉及含有所述产品的药物组合物及其用于制备药物的用途。
-
公开(公告)号:US07495110B2
公开(公告)日:2009-02-24
申请号:US10499384
申请日:2002-12-20
IPC分类号: A61K31/4184 , C07D235/28 , C07D235/30
CPC分类号: C07D231/12 , C07D233/56 , C07D235/28 , C07D235/30 , C07D249/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/06 , C07D471/04 , C07D471/10
摘要: A subject of the present application is new benzimidazole derivatives of formula in which A, Y, R1, R2, R3 and R4 represent different variable groups. These products have an antagonist activity of GnRH (Gonadotropin-Releasing Hormone). The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament.
摘要翻译: 本申请的主题是新的苯并咪唑衍生物,其中A,Y,R 1,R 2,R 3和R 4表示不同的可变基团。 这些产物具有GnRH(促性腺激素释放激素)的拮抗剂活性。 本发明还涉及含有所述产品的药物组合物及其用于制备药物的用途。
-
公开(公告)号:US20100279949A1
公开(公告)日:2010-11-04
申请号:US12315581
申请日:2008-12-04
申请人: Eric Ferrandis
发明人: Eric Ferrandis
CPC分类号: C07K14/415 , A61K38/00
摘要: A process for preparing recombinant heterocarpine with the complete sequence of heterocarpine (SEQ. ID. NO. 10), expression vectors comprising a polynucleotide encoding for heterocarpine, host cells transformed or transfected by said expression vectors as well as a process for obtaining heterocarpine by means of said transformed or transfected host cells are described wherein the recombinant heterocarpine obtained is used to treat cancer.
摘要翻译: 用于制备具有完整序列的异香草碱(SEQ ID NO:10)的重组异香草碱的方法,包含编码异香草碱的多核苷酸的表达载体,由所述表达载体转化或转染的宿主细胞以及通过手段获得异草甘膦的方法 描述了所述转化或转染的宿主细胞,其中所获得的重组异香草碱用于治疗癌症。
-
8.
公开(公告)号:US07494969B2
公开(公告)日:2009-02-24
申请号:US10522457
申请日:2003-08-25
CPC分类号: A61K36/75
摘要: A method of treating cancer dependent on growth factor GHRH in warm-blooded animals in need thereof with an isolated protein extended for Pilocarpus Heterophyllus.
摘要翻译: 一种在有需要的温血动物中治疗依赖于生长因子GHRH的癌症的方法,其具有扩展为Pilocarpus Heterophyllus的分离的蛋白质。
-
9.
公开(公告)号:US20080167221A9
公开(公告)日:2008-07-10
申请号:US10522457
申请日:2003-08-25
IPC分类号: A61K38/16 , C07K14/415
CPC分类号: A61K36/75
摘要: The invention relates to a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth is dependant on the GHRH growth factor and, in particular, for preparing a medicament that is intended for the treatment of cancers including small cell lung cancer and breast cancer.
摘要翻译: 本发明涉及结合人生长激素释放激素(hGHRH)的具有抗癌特性的植物来源的蛋白质。 所述蛋白质,其从所述皮毛菌属植物获得,特别适用于制备用于治疗生长依赖于GHRH生长因子的癌症的药物,特别是用于制备用于 治疗癌症包括小细胞肺癌和乳腺癌。
-
公开(公告)号:US07214533B2
公开(公告)日:2007-05-08
申请号:US10467436
申请日:2002-03-01
IPC分类号: C12N15/00
CPC分类号: C07K14/4702
摘要: The invention concerns a novel protein modulating cancer cell proliferation. The proteins encoded by the polynucleotides of the invention enable to determine the degree of malignity of abnormal cell proliferation.
摘要翻译: 本发明涉及调节癌细胞增殖的新型蛋白质。 由本发明的多核苷酸编码的蛋白质能够确定异常细胞增殖的恶性程度。
-
-
-
-
-
-
-
-
-